Opportunities and challenges in phage therapy for cardiometabolic diseases
Trends in Endocrinology & Metabolism · 2024-08 · 35 (8) · 687-696
DOI: 10.1016/j.tem.2024.03.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Endocrinology & Metabolism, 2024-08. Verfasst von Koen Wortelboer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Vascular Medicine, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Gastroenter…. Hauptthemen laut MEDLINE: Phage Therapy, Gastrointestinal Microbiome. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Vascular Medicine, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Gastroenterology, Endocrinology, and Metabolism, Endocrinology, Metabolism and Nu…
Zitieren
APA
Wortelboer, K., & Herrema, H. (2024). Opportunities and challenges in phage therapy for cardiometabolic diseases. Trends in Endocrinology & Metabolism, 35(8), 687-696. https://doi.org/10.1016/j.tem.2024.03.007
Vancouver
Wortelboer K, Herrema H. Opportunities and challenges in phage therapy for cardiometabolic diseases. Trends in Endocrinology & Metabolism. 2024;35(8):687-696. doi:10.1016/j.tem.2024.03.007
BibTeX
@article{Wortelboer2024,
author = {Wortelboer, Koen and Herrema, Hilde},
title = {Opportunities and challenges in phage therapy for cardiometabolic diseases},
journal = {Trends in Endocrinology & Metabolism},
year = {2024},
volume = {35},
number = {8},
pages = {687--696},
doi = {10.1016/j.tem.2024.03.007}
}
EUVIMED